Compare · EUCRU vs PDD
EUCRU vs PDD
Side-by-side comparison of Eucrates Biomedical Acquisition Corp. (EUCRU) and PDD Holdings Inc. (PDD): market cap, price performance, sector, and recent activity on the wire.
Summary
- EUCRU operates in Finance, while PDD operates in Consumer Discretionary - the two are in different parts of the market.
- PDD carries a market cap of $122.41B.
- PDD has hit the wire 6 times in the past 4 weeks while EUCRU has been quiet.
- PDD has more recent analyst coverage (25 ratings vs 0 for EUCRU).
- Company
- Eucrates Biomedical Acquisition Corp.
- PDD Holdings Inc.
- Price
- -
- -
- Market cap
- -
- $122.41B
- 1M return
- -
- +9.29%
- 1Y return
- -
- -23.84%
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2018
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
PDD Holdings Inc.
Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverage, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.
Latest EUCRU
No recent items for Eucrates Biomedical Acquisition Corp..
Latest PDD
- PDD Holdings upgraded by Macquarie with a new price target
- PDD Holdings upgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by PDD Holdings Inc.
- PDD Holdings Announces Third Quarter 2026 Unaudited Financial Results
- PDD Holdings to Report Third Quarter 2026 Unaudited Financial Results on November 19, 2026
- PDD Holdings downgraded by Morgan Stanley with a new price target
- PDD Holdings downgraded by Arete with a new price target
- Director Kam Anthony Ping Leung sold $140,151 worth of ADSs (1,705 units at $82.20), closing all direct ownership in the company (SEC Form 4)
- Director Kam Anthony Ping Leung converted options into 1,705 units of ADSs (SEC Form 4)
- SEC Form 6-K filed by PDD Holdings Inc.